These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 27903219)
1. Prediction of Plasma Concentration-time Profiles of Drugs in Humans from Animals Following Oral Administration: An Allometric Approach. Mahmood I Curr Drug Metab; 2016; 17(10):1006-1013. PubMed ID: 27903219 [TBL] [Abstract][Full Text] [Related]
2. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry. Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631 [TBL] [Abstract][Full Text] [Related]
3. Prediction of oral pharmacokinetics of cMet kinase inhibitors in humans: physiologically based pharmacokinetic model versus traditional one-compartment model. Yamazaki S; Skaptason J; Romero D; Vekich S; Jones HM; Tan W; Wilner KD; Koudriakova T Drug Metab Dispos; 2011 Mar; 39(3):383-93. PubMed ID: 21098644 [TBL] [Abstract][Full Text] [Related]
4. Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study. Mahmood I J Pharm Pharmacol; 1999 Aug; 51(8):905-10. PubMed ID: 10504028 [TBL] [Abstract][Full Text] [Related]
5. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach. Mahmood I Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171 [TBL] [Abstract][Full Text] [Related]
6. Allometric scaling and prediction of concentration-time profiles of coagulation factors in humans from animals. Mahmood I Xenobiotica; 2013 Sep; 43(9):774-9. PubMed ID: 23391211 [TBL] [Abstract][Full Text] [Related]
7. Prediction of clinical pharmacokinetic parameters of linezolid using animal data by allometric scaling: applicability for the development of novel oxazolidinones. Bhamidipati RK; Dravid PV; Mullangi R; Srinivas NR Xenobiotica; 2004 Jun; 34(6):571-9. PubMed ID: 15277016 [TBL] [Abstract][Full Text] [Related]
8. Prediction of Human Pharmacokinetics of Ulixertinib, a Novel ERK1/2 Inhibitor from Mice, Rats, and Dogs Pharmacokinetics. Suresh PS; Jairam RK; Chandrasekhar DV; Vinod AB; Hiremath RA; Raj A; Zainuddin M; Bhamidipati RK; Mullangi R Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):453-460. PubMed ID: 29470718 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods. Mahmood I; Yuan R Biopharm Drug Dispos; 1999 Apr; 20(3):137-44. PubMed ID: 10211866 [TBL] [Abstract][Full Text] [Related]
10. A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents. Mahmood I; Tegenge MA J Clin Pharmacol; 2019 Feb; 59(2):189-197. PubMed ID: 30192373 [TBL] [Abstract][Full Text] [Related]
11. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach. Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234 [TBL] [Abstract][Full Text] [Related]
12. Prediction of drug concentration-time data in humans from animals: a comparison of three methods. Mahmood I; Goteti K Xenobiotica; 2012 Aug; 42(8):756-65. PubMed ID: 22360447 [TBL] [Abstract][Full Text] [Related]
13. Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data? Caldwell GW; Masucci JA; Yan Z; Hageman W Eur J Drug Metab Pharmacokinet; 2004; 29(2):133-43. PubMed ID: 15230342 [TBL] [Abstract][Full Text] [Related]
14. Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics. Feng MR; Lou X; Brown RR; Hutchaleelaha A Pharm Res; 2000 Apr; 17(4):410-8. PubMed ID: 10870984 [TBL] [Abstract][Full Text] [Related]
15. Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach. Izumi T; Enomoto S; Hosiyama K; Sasahara K; Shibukawa A; Nakagawa T; Sugiyama Y J Pharmacol Exp Ther; 1996 Jun; 277(3):1630-41. PubMed ID: 8667232 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections. Marchbanks CR; Mikolich DJ; Mayer KH; Zinner SH; Dudley MN Antimicrob Agents Chemother; 1990 Oct; 34(10):1966-72. PubMed ID: 2291662 [TBL] [Abstract][Full Text] [Related]
17. Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds. Fura A; Vyas V; Humphreys W; Chimalokonda A; Rodrigues D Biopharm Drug Dispos; 2008 Nov; 29(8):455-68. PubMed ID: 18989850 [TBL] [Abstract][Full Text] [Related]
18. Prediction of drug concentration-time profiles in children from adults: an allometric approach. Mahmood I; Goteti K Am J Ther; 2015; 22(2):132-40. PubMed ID: 23676343 [TBL] [Abstract][Full Text] [Related]
19. Allometry Is a Reasonable Choice in Pediatric Drug Development. Liu T; Ghafoori P; Gobburu JV J Clin Pharmacol; 2017 Apr; 57(4):469-475. PubMed ID: 27649629 [TBL] [Abstract][Full Text] [Related]
20. Interspecies scaling: predicting oral clearance in humans. Mahmood I Am J Ther; 2002; 9(1):35-42. PubMed ID: 11782818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]